Can Omega-3 and black seed oil help beat COVID-19?
NCT ID NCT04553705
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed trial tested whether natural supplements like omega-3, black seed oil, Indian costus, and quinine could boost the immune system of 150 COVID-19 patients. Participants had mild to moderate symptoms and were monitored for recovery time, fever, lung inflammation, and other health markers. The goal was to see if these supplements could help the body fight the virus and reduce hospital stays.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Omega-3, black seed oil, Indian costus, quinine pills
- What this could lead to
- If effective, these supplements could help the immune system fight COVID-19 and speed recovery.
- What could go wrong
- This is a small, completed trial with no published results yet. Supplements are not a proven treatment and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
150 people
The number who actually took part.
- Started
-
Sep 2020
- Finished
-
Dec 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Symptomatic with respiratory or systemic symptoms * Positive nasopharyngeal swab for COVID-19 * CT imaging showing viral pneumonia * Temperature 38°C * Respiratory rate \< 25 /min * Oxygen saturation (pulse oximetry) \>95% Exclusion Criteria: * Pregnant or breast feeding * Hepatic failure Child-Pugh C * Negative swab test of (SARS)-(CoV-2) * Expected life is less than 24 hours * End-stage lung disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maternity and Children hospital
Mecca, Mecca Region, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home antibody tests put to the test: can you read your own COVID-19 result?
- COVID-19's hidden toll: muscle wasting in the ICU
- Can a mild case of COVID-19 harm your kidneys? urine tests may hold the answer
- Could a common acne pill weaken the nose's defense against COVID-19?
- Could cystic fibrosis offer hidden protection against COVID-19?
- Rewriting the code: a One-Time gene fix for a rare immune disease?